Evidence map›Paper›PMID 28938281›Full record

SynthesisJournal of orthopaedic trauma2017

Tranexamic Acid in Orthopaedic Trauma Surgery: A Meta-Analysis.

Elizabeth B Gausden, Rameez Qudsi, Myles D Boone, Brian OʼGara, Joseph J Ruzbarsky, Dean G Lorich

2 registry-linked trialsOpen access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Journal of orthopaedic trauma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 45 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 7 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05802238 phase2withdrawnnot on this mapstarted 2023, after this paper: background citation

Efficacy of Tranexamic Acid (TXA) in Humerus ORIF

TypeinterventionalSponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Ran2023 to 2024Enrolled0ConditionsFracture HumerusArmsTranexamic acid (TXA), Saline
NCT07625709 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Tranexamic Acid on Perioperative Blood Loss in Reamed Intramedullary Nailing of Diaphyseal Femoral and Tibial Fractures: A Prospective Comparative Study.

TypeinterventionalSponsorKathmandu University School of Medical SciencesRan2023 to 2025Enrolled54ConditionsBlood Loss, Postoperative, Blood Loss, Surgical, Femoral Fracture, Tibial FractureArmsIntervention with Tranexamic Acid, Control group (Normal Saline)
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 7 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Efficacy and Safety of Tranexamic Acid for Blood Salvage in Intertrochanteric Fracture Surgery: A Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Tranexamic acid in shoulder surgery: a narrative review.JSES reviews, reports, and techniques · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Effect of intravenous tranexamic acid on postoperative drainage and elbow joint function after traumatic elbow stiffness release].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elizabeth B Gausden*Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY; †Harvard Combined Orthopaedic Residency Program, Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA; ‡Department of Anesthesiology and Critical Care, Beth Israel Deaconess, Boston, MA; and §Department of Orthopaedic Surgery, Hospital for Special Surgery, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY.
Rameez Qudsi
Myles D Boone
Brian OʼGara
Joseph J Ruzbarsky
Dean G Lorich
Hospital for Special Surgery · USBrigham and Women's Hospital · US

Funding

Research Training for AnesthetistsT32GM007592 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STUART A FORMAN · 1985 to 2026
$11.8M
NHLBI NIH HHS L30 HL138811NIGMS NIH HHS T32 GM007592
6 · The paper itself

Abstract

aimTo systematically review and quantify the efficacy of tranexamic acid (TXA) use in reducing the risk of receiving a blood transfusion in patients undergoing orthopaedic trauma surgery, in reducing blood loss, and risk of thromboembolic events.

methodsA systematic literature search was performed using MEDLINE, Embase, ClinicalTrials.gov, and conference proceeding abstracts from 2014 to 2016. A minimum of 2 reviewers screened each study and graded quality. The primary outcome measure was the risk of receiving a blood transfusion in the TXA group versus control. A meta-analysis was performed to construct a combined odds ratio (OR) of receiving a blood transfusion, mean difference (MD) of blood loss, and OR of thromboembolic events.

resultsTwelve studies were included in the quantitative analysis (1,333 patients). The risk of blood transfusion was significantly less in patients who were administered TXA compared with controls [OR 0.407; 95% confidence interval (CI) 0.278-0.594, I = 34, Q = 17, P ≤ 0.001]. There was significantly less blood loss in the TXA group compared with controls, as the mean difference was 304 mL (95% CI, 142-467 mL) (I = 94, Q value = 103, P < 0.001). There was no significant difference in risk of symptomatic thromboembolic events (OR 0.968; 95% CI, 0.530-1.766, I = 0, Q value = 5, P = 0.684).

conclusionsIn patients with orthopaedic trauma, TXA reduces the risk of blood transfusion, reduces perioperative blood loss, and has no significant effect on the risk of symptomatic thromboembolic events. More high-quality studies are needed to ensure the safety of the drug in these patients. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

Indexed as

Antifibrinolytic AgentsBlood Loss, SurgicalCase-Control StudiesFemaleHumansMaleOrthopedic ProceduresOutcome Assessment, Health CareTranexamic AcidWounds and InjuriesAntifibrinolytic AgentsTranexamic Acid

Identifiers

PMID28938281
PMCPMC6827340
OpenAlexW2757672998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.